MedTrace Logo

T-TAS® wS Method Comparison

NCT06710262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2025-07-28

No results posted yet for this study

Summary

This study involves the collection of blood samples and measurement with the T-TAS PL assay to compare the performance of the T-TAS wS instrument to the T-TAS 01 instrument

Conditions

  • Antiplatelet Therapy
  • Healthy Donors
  • Von Willebrand Disease (VWD)

Interventions

DIAGNOSTIC_TEST

T-TAS PL Assay

The T-TAS PL assay is a flow chamber assay for measuring primary hemostatic function

Sponsors & Collaborators

  • ZACROS Corporation

    collaborator UNKNOWN

  • Hikari Dx, Inc.

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-21
Primary Completion
2025-07-14
Completion
2025-07-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06710262 on ClinicalTrials.gov